|
Volumn 326, Issue 7388, 2003, Pages 511-512
|
Neurocysticercosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBENDAZOLE;
PRAZIQUANTEL;
COMPUTER ASSISTED TOMOGRAPHY;
COST EFFECTIVENESS ANALYSIS;
CYSTICERCUS;
DRUG COST;
DRUG EFFICACY;
EDITORIAL;
ENDEMIC DISEASE;
EPILEPSY;
HUMAN;
HYDROCEPHALUS;
IMMUNE RESPONSE;
NEUROCYSTICERCOSIS;
NEUROSURGERY;
NUCLEAR MAGNETIC RESONANCE;
PARASITOLOGY;
PRIORITY JOURNAL;
SERODIAGNOSIS;
SOCIAL CLASS;
SURVIVAL;
TAENIA SOLIUM;
COST BENEFIT ANALYSIS;
POVERTY;
COST-BENEFIT ANALYSIS;
EPILEPSY;
HUMANS;
NEUROCYSTICERCOSIS;
POVERTY AREAS;
|
EID: 0037426022
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.326.7388.511 Document Type: Editorial |
Times cited : (23)
|
References (8)
|